Resource center
Webinar
In Part I of this webinar, we will describe discovery of therapeutic, diagnostic, and tool antibody candidates against the…
View
Webinar
Embark on a journey beyond traditional immunization: unveiling the potential of genetic immunization for unparalleled affinity with anti-idiotypic antibodies…
View
Press Release
Genovac becomes Carterra’s 100th LSA placement throughout the world. Fargo, North Dakota and Salt Lake City, Utah —…
View
Press Release
Fargo, North Dakota, Dec. 13, 2021 — Genovac, a contract research and manufacturing organization specializing in antibody discovery against…
View
Press Release
Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon Technology for Both Antibody Discovery and Cell…
View
Article
Time can be the most valuable asset in the drug and therapeutic development processes, especially in situations like the…
View
Article
Today’s biotechnology scientists and companies are focused more on working together in the drug and therapy development process to…
View
Press Release
Fargo, N.D. (May 4, 2021) – Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody…
View